BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garcia-Pagan JC, Valla DC. Portal vein thrombosis: a predictable milestone in cirrhosis? J Hepatol. 2009;51:632-634. [PMID: 19660824 DOI: 10.1016/j.jhep.2009.06.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Qi X, Su C, Ren W, Yang M, Jia J, Dai J, Xu W, Guo X. Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature. Clin Res Hepatol Gastroenterol 2015;39:683-91. [PMID: 25956490 DOI: 10.1016/j.clinre.2015.02.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
2 Ponziani FR, De Stefano V, Gasbarrini A. Viral cirrhosis: an overview of haemostatic alterations and clinical consequences. Mediterr J Hematol Infect Dis 2009;1:e2009033. [PMID: 21415961 DOI: 10.4084/MJHID.2009.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Qi X, Han G, He C, Yin Z, Zhang H, Wang J, Xia J, Cai H, Yang Z, Bai M, Wu K, Fan D. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis. Med Sci Monit 2012;18:HY37-41. [PMID: 22847208 DOI: 10.12659/msm.883252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 Loudin M, Ahn J. Portal Vein Thrombosis in Cirrhosis. J Clin Gastroenterol. 2017;51:579-585. [PMID: 28489645 DOI: 10.1097/mcg.0000000000000834] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Villa E, Cammà C, Marietta M, Luongo M, Critelli R, Colopi S, Tata C, Zecchini R, Gitto S, Petta S, Lei B, Bernabucci V, Vukotic R, De Maria N, Schepis F, Karampatou A, Caporali C, Simoni L, Del Buono M, Zambotto B, Turola E, Fornaciari G, Schianchi S, Ferrari A, Valla D. Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis. Gastroenterology 2012;143:1253-1260.e4. [DOI: 10.1053/j.gastro.2012.07.018] [Cited by in Crossref: 418] [Cited by in F6Publishing: 308] [Article Influence: 46.4] [Reference Citation Analysis]
6 Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol. 2010;16:143-155. [PMID: 20066733 DOI: 10.3748/wjg.v16.i2.143] [Cited by in CrossRef: 143] [Cited by in F6Publishing: 97] [Article Influence: 13.0] [Reference Citation Analysis]
7 Harding DJ, Perera MT, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol. 2015;21:6769-6784. [PMID: 26078553 DOI: 10.3748/wjg.v21.i22.6769] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 27] [Article Influence: 9.2] [Reference Citation Analysis]
8 Schwope RB, Katz M, Russell T, Reiter MJ, Lisanti CJ. The many faces of cirrhosis. Abdom Radiol (NY) 2020;45:3065-80. [PMID: 31190090 DOI: 10.1007/s00261-019-02095-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Amitrano L, Guardascione MA. Management of portal vein thrombosis in cirrhotic patients. Mediterr J Hematol Infect Dis. 2009;1:e2009014. [PMID: 21415954 DOI: 10.4084/mjhid.2009.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
10 Giannini EG, Savarino V. Which Anticoagulant Drug Should Be Used to Treat Portal Vein Thrombosis in Patients With Chronic Liver Disease? Clinical Gastroenterology and Hepatology 2013;11:103. [DOI: 10.1016/j.cgh.2012.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Pettinari I, Vukotic R, Stefanescu H, Pecorelli A, Morelli M, Grigoras C, Sparchez Z, Andreone P, Piscaglia F; BO-LIVES (BOlogna LIVEr vascular Studies). Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis. Am J Gastroenterol. 2019;114:258-266. [PMID: 30538290 DOI: 10.1038/s41395-018-0421-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 25] [Article Influence: 22.0] [Reference Citation Analysis]
12 Thornburg B, Desai K, Hickey R, Hohlastos E, Kulik L, Ganger D, Baker T, Abecassis M, Caicedo JC, Ladner D, Fryer J, Riaz A, Lewandowski RJ, Salem R. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort. J Vasc Interv Radiol 2017; 28: 1714-1721. e2. [PMID: 29050854 DOI: 10.1016/j.jvir.2017.08.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
13 Lai Q, Spoletini G, Pinheiro RS, Melandro F, Guglielmo N, Lerut J. From portal to splanchnic venous thrombosis: What surgeons should bear in mind. World J Hepatol 2014;6:549-58. [PMID: 25232448 DOI: 10.4254/wjh.v6.i8.549] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.1] [Reference Citation Analysis]
14 Stravitz RT. Algorithms for managing coagulation disorders in liver disease. Hepatol Int 2018;12:390-401. [PMID: 30066204 DOI: 10.1007/s12072-018-9886-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
15 Hung HC, Lee JC, Cheng CH, Wang YC, Wu TH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee WC. Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation. J Clin Med 2020;9:E1181. [PMID: 32326024 DOI: 10.3390/jcm9041181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Qi X, Chen H, Han G. Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis. Am J Med Sci 2013;346:38-44. [PMID: 23187296 DOI: 10.1097/MAJ.0b013e31826485fc] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
17 Bai DS, Xia BL, Zhang C, Ye J, Qian JJ, Jin SJ, Jiang GQ. Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial. Int J Surg 2019;64:16-23. [PMID: 30851458 DOI: 10.1016/j.ijsu.2019.02.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
18 Qi X, Han G, He C, Yin Z, Guo W, Niu J, Fan D. CT features of non-malignant portal vein thrombosis: a pictorial review. Clin Res Hepatol Gastroenterol. 2012;36:561-568. [PMID: 22883835 DOI: 10.1016/j.clinre.2012.05.021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
19 Gawande R, Jalaeian H, Niendorf E, Olgun D, Krystosek L, Rubin N, Spilseth B. MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: Value of post contrast imaging with subtraction. Eur J Radiol 2019;118:88-95. [PMID: 31439264 DOI: 10.1016/j.ejrad.2019.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
20 El-Zayadi AR, Badran HM, Shawky S, Emara S, El-Bareedy A, Sobhi M. Effect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patients. Hepatol Int 2010;4:500-6. [PMID: 20827407 DOI: 10.1007/s12072-010-9170-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Seijo S, Garcia-Pagan JC. Anticoagulation in cirrhosis: ready … set … wait! Hepatology 2013;58:1175-6. [PMID: 23703896 DOI: 10.1002/hep.26503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
22 Andriulli A, Tripodi A, Angeli P, Senzolo M, Primignani M, Giannini EG, Riggio O, Colli A, Prati D, Sacerdoti D, Merkel C, Basili S, Ferro D, Villa E, Di Minno G, Caraceni P, Marzioni M, Mannucci PM, Violi F, Piscaglia F, Calvaruso V, De Pietri L, Falcone M, Feltracco P, Grandone E, La Mura V, Licata A, Lucidi C, Maimone S, Marietta M, Morisco F, Napoleone L, Piano S, Raparelli V, Rebulla P, Ribero D, Sartori MT, Scalera A, Schepis F, Siciliano M, Baroni GS, Tufano A, Vitale A, Zuin M. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. Digestive and Liver Disease 2016;48:455-67. [DOI: 10.1016/j.dld.2016.02.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 6.2] [Reference Citation Analysis]
23 Zhan C, Prabhu V, Kang SK, Li C, Zhu Y, Kim S, Olsen S, Jacobson IM, Dagher NN, Carney B, Hickey RM, Taslakian B. Comparison of Non-Tumoral Portal Vein Thrombosis Management in Cirrhotic Patients: TIPS Versus Anticoagulation Versus No Treatment. J Clin Med 2021;10:2316. [PMID: 34073236 DOI: 10.3390/jcm10112316] [Reference Citation Analysis]
24 Fontana RJ. Prophylactic Anticoagulation in Cirrhotics: A Paradox for Prime Time? Gastroenterology 2012;143:1138-41. [DOI: 10.1053/j.gastro.2012.09.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
25 Hoolwerf EW, Kraaijpoel N, Büller HR, van Es N. Direct oral anticoagulants in patients with liver cirrhosis: A systematic review. Thromb Res 2018;170:102-8. [PMID: 30153564 DOI: 10.1016/j.thromres.2018.08.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
26 Valeriani E, Di Nisio M, Riva N, Cohen O, Porreca E, Senzolo M, De Gottardi A, Magaz M, Garcia-Pagan JC, Ageno W. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Thromb Haemost 2021;121:867-76. [PMID: 33525037 DOI: 10.1055/s-0040-1722192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol. 2012;57:203-212. [PMID: 22446690 DOI: 10.1016/j.jhep.2011.12.034] [Cited by in Crossref: 133] [Cited by in F6Publishing: 104] [Article Influence: 14.8] [Reference Citation Analysis]
28 Basit SA, Stone CD, Gish R. Portal vein thrombosis. Clin Liver Dis. 2015;19:199-221. [PMID: 25454305 DOI: 10.1016/j.cld.2014.09.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
29 del Carmen Manzano-robleda M, Barranco-fragoso B, Uribe M, Méndez-sánchez N. Portal vein thrombosis: What is new? Annals of Hepatology 2015;14:20-7. [DOI: 10.1016/s1665-2681(19)30797-5] [Cited by in Crossref: 34] [Article Influence: 5.7] [Reference Citation Analysis]
30 Cerini F, Garcia-pagán JC. Thromboprophylaxis with heparin in hospitalized patients with cirrhosis: friend or foe. Liver Int 2014;34:971-3. [DOI: 10.1111/liv.12453] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]